The future of gene therapy

Nature

Volumn 427, Issue 6977, 2004, Pages 779-781

  Cavazzana Calvo, Marina ^a   Thrasher, Adrian ^b   Mavillo, Fulvio ^c,d  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RETROVIRUS VECTOR;

CANCER; CARCINOGENESIS; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; EUROPE; GENE INSERTION; GENE THERAPY; GENETIC DISORDER; GENETICS; HUMAN; LEGAL ASPECT; LEUKEMIA; NONHUMAN; NOTE; PATHOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SAFETY; SCID MOUSE; STANDARD; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; UNITED STATES;

INSERTION SEQUENCES; UNIDENTIFIED RETROVIRUS;

EID: 1542319138     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/427779a     Document Type: Note

References (9)

1. Cavazzana-Calvo, M. et al. Science 288, 669-672 (2000).
2. Aiuti, A. et al. Science 296, 2410-2413 (2002).
3. Hacein-Bey-Abina, S. et al. Science 302, 415-419 (2003).
4. Fischer, A. Lancet 357, 1863-1869 (2001).
5. Antoine, C. et al. Lancet 361, 553-560 (2003).
6. Bonini, C. et al. Nature Med. 9, 367-369 (2003).
7. Dave, U. P., Jenkins, N. A. & Copeland, N. G. Science 303, 333 (2004).
8. Baum, C. et al. Blood 101, 2099-2114 (2003).
9. Williams, D. A. & Baum, C. Science 302, 400-401 (2003).